• OPEN AN ACCOUNT
Indian Indices
Nifty
17,277.95 128.85
(0.75%)
Sensex
57,858.15 366.64
( 0.64%)
Bank Nifty
37,706.75 759.20
( 2.05%)
Nifty IT
34,707.45 -114.15
( -0.33%)
Global Indices
Nasdaq
13,539.30 -315.83
(-2.28%)
Dow Jones
34,297.73 -66.77
(-0.19%)
Hang Seng
24,289.90 46.29
(0.19%)
Nikkei 225
27,011.33 -120.01
(-0.44%)
Forex
USD-INR
74.63 0.15
(0.20%)
EUR-INR
84.31 -0.01
(-0.01%)
GBP-INR
100.63 0.02
(0.02%)
JPY-INR
0.66 0.00
(0.13%)

EQUITY - MARKET SCREENER

Mystic Electronics Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
535205
INE159O01033
16.8246639
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
16.9
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

sun pharmaceuticals industries ltd
Sun Pharma gets US FDA approval for Amphotericin B injection
Dec 16,2021

The generic product approval is based on AmBisome Liposome for injection, 50 mg/vial as a reference product.

Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. The fungal infections it is used to treat include mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis.

Sun Pharma has been granted Competitive Generic Therapy (CGT) designation by US FDA and being the first approved generic, is eligible for 180 days of CGT exclusivity for the product.

As per October 2021 IQVIA Health data, AmBisome Liposome for injection, 50mg/vial had annualized sales of approximately $136 million in USA.

Sun Pharmaceutical Industries is the world's fourth-largest specialty generic pharmaceutical company and India's top pharmaceutical company.

The company's consolidated net profit rose 12.92% to Rs 2047.01 crore on 12.54% increase in total revenue from operations to Rs 9625.93 crore in Q2 September 2021 over Q2 September 2020.

The scrip shed 0.91% to currently trade at Rs 768.50 on the BSE.